000290087 001__ 290087
000290087 005__ 20240510175949.0
000290087 0247_ $$2doi$$a10.3324/haematol.2023.284310
000290087 0247_ $$2ISSN$$a0390-6078
000290087 0247_ $$2ISSN$$a1592-8721
000290087 037__ $$aDKFZ-2024-00986
000290087 082__ $$a610
000290087 1001_ $$aKayser, Sabine$$b0
000290087 245__ $$aImpact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease
000290087 260__ $$aPavia$$bFerrata Storti Foundation$$c2024
000290087 3367_ $$2DRIVER$$aarticle
000290087 3367_ $$2DataCite$$aOutput Types/Journal article
000290087 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1715338456_25992
000290087 3367_ $$2BibTeX$$aARTICLE
000290087 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000290087 3367_ $$00$$2EndNote$$aJournal Article
000290087 536__ $$0G:(DE-HGF)POF4-319H$$a319H - Addenda (POF4-319H)$$cPOF4-319H$$fPOF IV$$x0
000290087 588__ $$aDataset connected to CrossRef, Journals: inrepo02.dkfz.de
000290087 7001_ $$aSartor, Chiara$$b1
000290087 7001_ $$aGiglio, Fabio$$b2
000290087 7001_ $$aBruno, Alessandro$$b3
000290087 7001_ $$aWebster, Jonathan$$b4
000290087 7001_ $$aChiusolo, Patrizia$$b5
000290087 7001_ $$aSaraceni, Francesco$$b6
000290087 7001_ $$aGuerzoni, Selene$$b7
000290087 7001_ $$aPochintesta, Lara$$b8
000290087 7001_ $$aBorlenghi, Erika$$b9
000290087 7001_ $$aMarconi, Giovanni$$b10
000290087 7001_ $$aZacheo, Irene$$b11
000290087 7001_ $$aCerrano, Marco$$b12
000290087 7001_ $$aSalutari, Prassede$$b13
000290087 7001_ $$aRestuccia, Francesco$$b14
000290087 7001_ $$aAbbenante, Mariachiara$$b15
000290087 7001_ $$aLevis, Mark J.$$b16
000290087 7001_ $$aSchlenk, Richard F.$$b17
000290087 7001_ $$aPapayannidis, Cristina$$b18
000290087 773__ $$0PERI:(DE-600)2805244-4$$a10.3324/haematol.2023.284310$$n5$$p1385–1392$$tHaematologica$$v109$$x0390-6078$$y2024
000290087 909CO $$ooai:inrepo02.dkfz.de:290087$$pVDB
000290087 9131_ $$0G:(DE-HGF)POF4-319H$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vAddenda$$x0
000290087 9141_ $$y2024
000290087 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-23
000290087 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-23
000290087 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-08-23
000290087 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-06-05T07:07:08Z
000290087 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-06-05T07:07:08Z
000290087 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Peer review$$d2023-06-05T07:07:08Z
000290087 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-23
000290087 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-08-23
000290087 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-08-23
000290087 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-23
000290087 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-08-23
000290087 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-08-23
000290087 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-08-23
000290087 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-08-23
000290087 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-08-23
000290087 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-08-23
000290087 9201_ $$0I:(DE-He78)W010-20160331$$kW010$$lKlinische Studienzentrale$$x0
000290087 980__ $$ajournal
000290087 980__ $$aVDB
000290087 980__ $$aI:(DE-He78)W010-20160331
000290087 980__ $$aUNRESTRICTED